488 related articles for article (PubMed ID: 16259349)
1. Allopurinol-induced DRESS syndrome.
Markel A
Isr Med Assoc J; 2005 Oct; 7(10):656-60. PubMed ID: 16259349
[TBL] [Abstract][Full Text] [Related]
2. Allopurinol-induced recurrent DRESS syndrome: pathophysiology and treatment.
Shalom R; Rimbroth S; Rozenman D; Markel A
Ren Fail; 2008; 30(3):327-9. PubMed ID: 18350453
[TBL] [Abstract][Full Text] [Related]
3. [Fatal liver necrosis due to allopurinol].
Pereira S; Almeida J; Silva AO; Quintas M; Candeias O; Freitas F
Acta Med Port; 1998 Dec; 11(12):1141-4. PubMed ID: 10192993
[TBL] [Abstract][Full Text] [Related]
4. Hyperuricemia and gout.
Sloan RW
J Fam Pract; 1982 May; 14(5):923-6, 930-1, 934. PubMed ID: 7042900
[TBL] [Abstract][Full Text] [Related]
5. Relationship between serum urate and plasma oxypurinol in the management of gout: determination of minimum plasma oxypurinol concentration to achieve a target serum urate level.
Stamp LK; Barclay ML; O'Donnell JL; Zhang M; Drake J; Frampton C; Chapman PT
Clin Pharmacol Ther; 2011 Sep; 90(3):392-8. PubMed ID: 21796116
[TBL] [Abstract][Full Text] [Related]
6. [A case of vanishing bile duct syndrome associated with hypersensitivity to allopurinol].
Choi SH; Yang SH; Song YB; Kim HJ; Seo YT; Choi DS; Moon KH; Byun JH; Yu ES
Korean J Hepatol; 2005 Mar; 11(1):80-5. PubMed ID: 15788888
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of febuxostat treatment in subjects with gout and severe allopurinol adverse reactions.
Chohan S
J Rheumatol; 2011 Sep; 38(9):1957-9. PubMed ID: 21724706
[TBL] [Abstract][Full Text] [Related]
8. Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout.
Dalbeth N; Kumar S; Stamp L; Gow P
J Rheumatol; 2006 Aug; 33(8):1646-50. PubMed ID: 16783857
[TBL] [Abstract][Full Text] [Related]
9. Allopurinol dosing in renal impairment: walking the tightrope between adequate urate lowering and adverse events.
Dalbeth N; Stamp L
Semin Dial; 2007; 20(5):391-5. PubMed ID: 17897242
[TBL] [Abstract][Full Text] [Related]
10. [Side effects off allopurinol].
Rødevand E; Sletvold O; Kvande KT
Tidsskr Nor Laegeforen; 2004 Oct; 124(20):2618-9. PubMed ID: 15534635
[TBL] [Abstract][Full Text] [Related]
11. Allopurinol Induced DRESS Syndrome.
Pawar P; Gupta VA; Karnik ND; Vaidya M; Khopkar U
J Assoc Physicians India; 2014 Nov; 62(11):63-5. PubMed ID: 26281488
[TBL] [Abstract][Full Text] [Related]
12. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
[TBL] [Abstract][Full Text] [Related]
13. A review of inpatients with adverse drug reactions to allopurinol.
Khoo BP; Leow YH
Singapore Med J; 2000 Apr; 41(4):156-60. PubMed ID: 11063179
[TBL] [Abstract][Full Text] [Related]
14. Fatal allopurinol hypersensitivity syndrome after treatment of asymptomatic hyperuricaemia.
Gutiérrez-Macías A; Lizarralde-Palacios E; Martínez-Odriozola P; Miguel-De la Villa F
BMJ; 2005 Sep; 331(7517):623-4. PubMed ID: 16166134
[No Abstract] [Full Text] [Related]
15. [Allopurinol-induced hypersensitivity syndrome].
Kinyó A; Lakatos A; Varga A; Gyulai R; Varga E; Bata-Csörgő Z; Kemény L
Orv Hetil; 2012 Apr; 153(15):586-91. PubMed ID: 22472359
[TBL] [Abstract][Full Text] [Related]
16. Allopurinol-induced drug reaction with eosinophilia and systemic symptoms syndrome with recurrence.
Yang DC; Chang CM
J Am Geriatr Soc; 2010 Oct; 58(10):2043-4. PubMed ID: 20929487
[No Abstract] [Full Text] [Related]
17. Allopurinol hypersensitivity syndrome: a preventable severe cutaneous adverse reaction?
Lee HY; Ariyasinghe JT; Thirumoorthy T
Singapore Med J; 2008 May; 49(5):384-7. PubMed ID: 18465047
[TBL] [Abstract][Full Text] [Related]
18. Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol.
Stamp LK; Taylor WJ; Jones PB; Dockerty JL; Drake J; Frampton C; Dalbeth N
Arthritis Rheum; 2012 Aug; 64(8):2529-36. PubMed ID: 22488501
[TBL] [Abstract][Full Text] [Related]
19. Febuxostat: new drug. Hyperuricaemia: risk of gout attacks.
Prescrire Int; 2009 Apr; 18(100):63-5. PubMed ID: 19585722
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic alternatives in a patient with DRESS syndrome induced by allopurinol.
Calogiuri GF; Satriano F; Muratore L; Valacca A; Nettis E; Di Leo E; Vacca A
J Investig Allergol Clin Immunol; 2009; 19(4):333-4. PubMed ID: 19639739
[No Abstract] [Full Text] [Related]
[Next] [New Search]